Are Retatrutide and Tirzepatide in the same research category?

Yes. Both are catalogued under metabolic pathway research, and they share research areas including Receptor binding assays and In vitro receptor pharmacology. Shared categorisation is not a statement that they behave the same way or that one can replace the other.

Do Retatrutide and Tirzepatide need the same storage conditions?

Both are specified at 2–8 °C (lyophilized, sealed) in sealed lyophilized or supplied form, so a single storage location covers both. Always follow the condition printed on the vial label and the published COA for the lot you received.

Which does VaultLabs stock, Retatrutide or Tirzepatide?

Both. Retatrutide is listed as 2 catalog skus and Tirzepatide as 1 catalog sku, each dispatched from the UAE with lot details you can check through batch verification before ordering.

Can Retatrutide be substituted for Tirzepatide in an experiment?

No substitution guidance is provided. Material selection belongs to the validated protocol of the receiving laboratory, which should be based on published specifications and the COA for the specific lot. VaultLabs supplies reference materials and documentation only.

Does this comparison include human outcome data?

No. It describes catalog specifications, supplied form, storage requirements and published research categories. VaultLabs does not provide medical, dosing or human-use information for any compound.

Compound comparison

Retatrutide vs Tirzepatide

Retatrutide and Tirzepatide are both catalogued under metabolic pathway research, which is why laboratories often weigh one against the other. This page compares their published specifications, supplied form, storage requirements and VaultLabs catalog status side by side. Specifications and research context only — no dosing, protocol or human-use guidance.

Research use only. For in vitro research use only. Not for human or animal consumption. Not for human consumption, medical use, or personal application.

Attribute	Retatrutide	Tirzepatide
Category	Metabolic pathway research	Metabolic & incretin research
Compound type	Multi-receptor agonist peptide (research literature)	Incretin dual-agonist peptide
CAS number (literature)	Not published	2023788-19-2 (literature)
Supplied form	Lyophilized powder (GLP-3 RT 10 mg / 20 mg presentations)	Lyophilized powder
Appearance	White to off-white lyophilized material	White to off-white lyophilized material
Storage temperature	2–8 °C (lyophilized, sealed)	2–8 °C (lyophilized, sealed)
Primary research area	Receptor binding assays	Dual incretin receptor pharmacology
Also referenced as	GLP-3 RT, Reta, RETA (colloquial for retatrutide)	LY3298176, dual GIP/GLP-1 agonist peptide
Batch verification	Lot lookup available	Lot lookup available
VaultLabs catalog	2 catalog SKUs	1 catalog SKU

Shared research areas

Receptor binding assays
In vitro receptor pharmacology

Key differences

Material type differs — Retatrutide is supplied as multi-receptor agonist peptide (research literature), Tirzepatide as incretin dual-agonist peptide.
Presentation differs — Lyophilized powder (GLP-3 RT 10 mg / 20 mg presentations) vs Lyophilized powder.
Primary literature focus — Receptor binding assays vs Dual incretin receptor pharmacology.

Storage comparison

Both are stored at 2–8 °C (lyophilized, sealed), so they can share the same cold-chain and inventory conditions. Retatrutide: 2–8 °C · protect from light. Tirzepatide: 2–8 °C sealed; temperature-aware UAE dispatch recommended.

FAQ

Catalog availability

Presentations VaultLabs currently lists, dispatched from the UAE. Check the lot against batch verification before ordering.

Retatrutide

Tirzepatide

tirzepatide 30mg

Retatrutide overview Tirzepatide overview All comparisons